BMO Capital Maintains Outperform on TrueBlue, Lowers Price Target to $6
Benzinga Newsdesk 12 months ago
NewsPrice TargetAnalyst Ratings
BMO Capital analyst Jeffrey Silber maintains TrueBlue (NYSE:TBI) with a Outperform and lowers the price target from $8 to $6.
BMO Capital analyst Jeffrey Silber maintains TrueBlue (NYSE:TBI) with a Outperform and lowers the price target from $8 to $6.